SHOCKWAVE MED INC's ticker is SWAV and the CUSIP is 82489T104. A total of 139 filers reported holding SHOCKWAVE MED INC in Q2 2020. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $10,988,058 | -49.6% | 33,744 | -70.5% | 0.00% | -66.7% |
Q4 2023 | $21,817,404 | +410.2% | 114,491 | +433.1% | 0.01% | +500.0% |
Q3 2023 | $4,275,871 | -79.5% | 21,476 | -70.7% | 0.00% | -85.7% |
Q2 2023 | $20,891,727 | -35.6% | 73,199 | -51.1% | 0.01% | -46.2% |
Q1 2023 | $32,454,463 | +595.7% | 149,677 | +559.7% | 0.01% | +550.0% |
Q4 2022 | $4,665,085 | -62.9% | 22,689 | -49.8% | 0.00% | -60.0% |
Q3 2022 | $12,559,000 | +9.3% | 45,166 | -24.8% | 0.01% | 0.0% |
Q2 2022 | $11,486,000 | -72.9% | 60,085 | -70.6% | 0.01% | -61.5% |
Q1 2022 | $42,399,000 | +189.1% | 204,468 | +148.6% | 0.01% | +225.0% |
Q4 2021 | $14,667,000 | -7.6% | 82,244 | +6.7% | 0.00% | -20.0% |
Q3 2021 | $15,866,000 | +35.8% | 77,065 | +25.2% | 0.01% | 0.0% |
Q2 2021 | $11,682,000 | +385.9% | 61,568 | +233.5% | 0.01% | +400.0% |
Q1 2021 | $2,404,000 | +46.4% | 18,459 | +16.6% | 0.00% | 0.0% |
Q4 2020 | $1,642,000 | -34.6% | 15,834 | -52.2% | 0.00% | -50.0% |
Q3 2020 | $2,509,000 | +139.9% | 33,100 | +49.8% | 0.00% | +100.0% |
Q2 2020 | $1,046,000 | – | 22,094 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prossimo Advisors, LLC | 18,758 | $3,735 | 8.81% |
Matisse Capital | 22,175 | $4,415,043 | 3.12% |
Atika Capital Management LLC | 116,500 | $23,195,150 | 3.04% |
APEIRON CAPITAL Ltd | 18,300 | $3,643,530 | 2.44% |
AtonRa Partners | 4,374 | $870,863 | 1.83% |
Rhenman & Partners Asset Management AB | 81,000 | $16,127,100 | 1.74% |
GILDER GAGNON HOWE & CO LLC | 549,173 | $109,340,363 | 1.66% |
Eversept Partners, LP | 84,462 | $16,816,384 | 1.42% |
Biondo Investment Advisors, LLC | 37,451 | $7,456,394 | 1.40% |
DEEPWATER ASSET MANAGEMENT, LLC | 15,321 | $3,050,411 | 1.40% |